Lloyd Technologies, Inc. develops medical disinfection technologies to help fight Hospital Acquired Infections (HAI's) and Multi-Drug Resistant Organisms (MDRO's). We have been developing better disinfection technology solutions since 2015, well before COVID-19, when we started developing novel UV disinfection technologies for occupied environments, with two granted patents (US 10,195,300 and US 10,639,390) and other patent pending inventions. We will soon be introducing a new family of patent-pending innovations focused on reducing Catheter Associated Urinary Tract Infections (CAUTI's) and other catheter induced illnesses and injuries. We are also developing a novel solution to help reduce "forever chemicals" in the environment, including PFAS, “Gen-X,” Persistent Organic Pollutants, etc., for which we were awarded US patent 11,512,013. Our technologies are available for license or co-development with suitable partners.

Led multi-national, multi-functional, multi-business-unit team focused on developing novel, value adding fluoropolymers for use in semi-conductors, displays, and other applications. Developed new products for energy storage applications and made major contributions to other BU and SBU technical programs.

Conceived alternative means to solve critical PFOA replacement problem affecting entire global Teflon(R) enterprise. Identified major cost reduction opportunities during economic downturn.

Created and used technology assessment methodology that was adopted corporate wide. Developed new products and processes for perfluorinated sulfonic acid polymer business.

Corporate Process Development Program Manager, CR&D, Wilmington, DESmall Lots Development (Pilot Plant) Operations Supervisor, Polymers R&D, Glasgow, DEField Engineering Design Office Supervisor, Lycra(R) Capital Expansion, Waynesboro, VATechnical Service Engineer, Refinish Paints, Troy, MIAssistance to Operations, Aniline Manufacturing Plant, Beaumont, TXDesign Engineer, Conoco Corporate Engineering, Ponca City, OK